Europe Prefilled Syringes Market: Industry Analysis and Forecast (2024-2030)

  • The Europe Prefilled Syringes Market size was valued at USD 2.30 Bn. in 2023 and the total Europe Prefilled Syringes Market revenue is expected to grow at a CAGR of 5.9 % from 2024 to 2030, reaching nearly USD 3.44 Bn. by 2030.

  • Format : PDF | Report ID : SMR_1752

Europe Prefilled Syringes Market Overview

A prefilled syringe is defined as a syringe that is already filled and correctly labelled before it enters the final clinical area, where it is been administered immediately without further manipulation.


The report has covered several factors of Europe Prefilled Syringes Market Dynamics that focused on the growth drivers, opportunities, challenges and restraints. The in-depth analysis of market leaders strategies that used while planning the product as well as marketing strategies and tactics that adopted by the them. The Report has segmented the product by various factors that propelled the market growth in Europe. Prefilled syringes are widely used in Europe owing to their convenience, safety, and ease of use. They offer numerous advantages over traditional vial and syringe systems, including reduced risk of contamination, accurate dosing, and improved patient compliance. As a result, the market for prefilled syringes in Europe has been experiencing steady growth.

Europe Prefilled Syringes Market


To get more Insights: Request Free Sample Report


Europe Prefilled Syringes Market Dynamics

Driving Factors and Advantages Propelling the Growth of Prefilled Syringes in Europe's Pharmaceutical Industry

Surged in the Prefilled syringes in Europe owing to an increase in the pharmaceutical Industry.  Factors influencing the growth of the European prefilled syringes market are ease of use, increased chronic disease, and technological advancement propelled the market growth in Europe.


Prefilled syringes are becoming increasingly popular in the pharmaceutical industry as they offer Convenience to the patient to use without the help of a nurse. Convenience is one of the major benefits of prefilled syringes. These syringes save the time and effort of healthcare professionals as it do not have to fill the syringe with medicine manually. Additionally, prefilled syringes are easy to transport and are able to store easily. Patients also benefit from the convenience, as healthcare professionals administer the syringe quickly without having to measure the dose or mix the medication with another solution.


One of the most significant advantages of prefilled syringes is improved safety. The chances of medication errors are reduced when using a prefilled syringe. The increasing adoption rate of Prefilled syringes in healthcare professionals who don't have to worry about over or under-dosing the patient, which is a common issue with traditional methods of medication delivery has accelerated the market growth in Europe. In addition, the risk of infection or other complications is also reduced with the help of prefilled syringes as a result there is an increase in the demand in Europe.  


Challenges Facing Prefilled Syringe Manufacturers in Europe

Prefilled syringe manufacturers faces several challenges with regard to product approval, labelling, and quality control due to stringent regulations imposed by European agencies like the European Medicines Agency (EMA) and individual national regulations that hinder the market growth. The increase in fierce competition among the companies competing for market share in the prefilled syringe market in Europe, which is growing and also minor manufacturers also find it difficult to compete with established firms because it frequently participate in price wars and aggressive marketing tactics. Prefilled syringe availability in the market has been impacted by supply chain disruptions, which had resulted in shortages and higher costs. These disruptions has led to delays in manufacturing process, shortages of raw materials, and problems with transportation.


Europe Prefilled Syringes Market Segment Analysis

Based on Type, the Disposable Prefilled Syringes segment holds the highest share in Europe and is expected to maintain its dominance during the forecast period. Compared to a vial containment system, a disposable prefilled syringe system produces fewer particles during drug administration. Additionally, the drug delivery system guarantees increased convenience and efficiency. The disposable syringes market has grown as a result of manufacturers introducing new products and technological innovations aimed at enhancing parenteral administration's ease, compliance, and convenience.


Based on Material Type, the Glass Syringes segment holds the largest share with a growing CAGR and is expected to boost the market growth during the forecast period. Glass syringes that are prefilled find numerous uses in a variety of contexts. These include long-term therapies for chronic conditions that patients use at home, pediatric vaccines given at a doctor's office, and ophthalmic treatments offered at specialty clinics. Hepatitis, influenza, and tetanus are just a few of the numerous vaccinations that are increasingly being administered via PFS. Prefilled glass syringes and auto-injectors be used to treat diabetes, autoimmune diseases, and even some cancers. Prefilled glass syringes and auto-injectors will probably be used to support patients outside of clinics and hospitals as a result of developing drug technologies, particularly for biologics.

Europe Prefilled Syringes Market1

Europe Prefilled Syringes Market Regional Analysis

Italy dominated the European prefilled syringes owing to the higher manufacturers of syringes in the country has boosted the demand for the Prefilled syringes market. A large number of hospitals and a rise in Research and development in the pharmaceutical companies for several syringes has boosted the market growth in Italy.  The increasing number of manufacturers in Italy for Prefilled syringes has propelled the market growth in Italy.  For example, D.B.M. is an outstanding manufacturer of Italian-made pre-filled syringes. Its production process is characterized by strict quality control, careful selection of raw materials, and terminal sterilization in a moist heat autoclave.


Germany is the fastest growing in the European prefilled syringes market in 2023 and is expected to grow with an increasing CAGR during the forecast year. The rising incidence of chronic disease and the increase in the need to maintain health status have propelled the market in Europe. Everyone in Germany is required to have insurance, which lowers the cost of treatments for patients and increases the demand for quality medical care and pharmaceuticals.


United Kingdom, France, Spain, and Rest of Europe is witnessing steady growth in prefilled syringes and is expected to grow during the forecast period owing to the increase in the number of disease and rise in concern about health issues is expected to be major factors for the growth.

Europe Prefilled Syringes Market2

Europe Prefilled Syringes Market Competitive Landscape

  • In April 2023, Delta Med Group announced a strategic partnership with DBM, a leading manufacturer of pre-filled syringes to strengthen their positioning in the pre-filled syringes market. Delta Med Group and DBM have increased their portfolio profiting from highly complementary products and R&D capabilities, improving their ability to serve customers. The partnership has generated significant synergies and boosted the growth trajectory of the combined entity.


           Europe Prefilled Syringes Market Scope

Market Size in 2023

USD 2.30 Bn.

Market Size in 2030

USD 3.44 Bn.

CAGR (2024-2030)


Historic Data

2018 - 2022

Base Year


Forecast Period


Segment Scope


By Type

  • Disposable Prefilled Syringes
  • Reusable Prefilled Syringes

By Material

  • Glass Prefilled Syringes
  • Plastic Prefilled Syringes

By Design

  • Single Chamber Prefilled Syringes
  • Dual Chamber Prefilled Syringes
  • Customized Prefilled Syringes

By Therapeutics

  • Large Molecules
  • Small Molecules


By Application

  • Anaphylaxis
  • Rheumatoid Arthritis
  • Diabetes
  • Others

Country Scope

  • Germany
  • United Kingdom
  • Spain
  • France
  • Italy
  • Belgium
  • Sweden
  • Poland
  • Russia


Europe Prefilled Syringes Market Key Players

  1. Delta Med SpA
  2. Onko Kocsel
  3. Italfarmaco
  4. Polpharma
  5. ROVI
  6. Becton, Dickinson and Company (BD)
  7. Gerresheimer AG
  8. Schott AG
  9. Stevanato Group
  10. Fresenius Kabi AG
  11. Vetter Pharma International GmbH

Frequently Asked Questions

Rising prevalence of Chronic Disease is expected to be the major driver for the market.

1.    Europe Prefilled Syringes Market Introduction
1.1.    Study Assumption and Market Definition
1.2.    Scope of the Study
1.3.    Executive Summary 
1.4.    Emerging Technologies
1.5.    Market Projections
1.6.    Strategic Recommendations
2.    Europe Prefilled Syringes Market Trends
2.1.    Market Consolidation
2.2.    Adoption of Advanced Technologies
2.3.    Pricing and Reimbursement Trends
3.    Europe Prefilled Syringes Market: Dynamics
3.1.1.    Market Drivers
3.1.2.    Market Restraints 
3.1.3.    Market Opportunities
3.1.4.    Market Challenges

3.2.    PORTER’s Five Forces Analysis
3.3.    PESTLE Analysis
3.4.    Regulatory Landscape
3.5.    Analysis of Government Schemes and Initiatives for the Europe Prefilled Syringes  Industry
4.    Europe Prefilled Syringes Market Size and Forecast by Segments (by Value USD)
4.1.    Europe Prefilled Syringes Market Size and Forecast, by Type (2024-2030)
4.1.1.    Disposable Prefilled Syringes
4.1.2.    Reusable Prefilled Syringes

4.2.     Europe Prefilled Syringes Market Size and Forecast, by Material  (2024-2030)
4.2.1.    Glass Prefilled Syringes
4.2.2.    Plastic Prefilled Syringes

4.3.    Europe Prefilled Syringes Market Size and Forecast, by Design  (2024-2030)
4.3.1.    Single Chamber Prefilled Syringes
4.3.2.    Dual Chamber Prefilled Syringes

4.4.    Europe Prefilled Syringes Market Size and Forecast, by Application  (2024-2030)
4.4.1.    Anaphylaxis
4.4.2.    Rheumatoid Arthritis
4.4.3.    Diabetes
4.4.4.    Others

4.5.    Europe Prefilled Syringes Market Size and Forecast, by Country (2023-2030)
4.5.1.    United Kingdom
4.5.2.    France
4.5.3.    Germany
4.5.4.    Italy
4.5.5.    Spain
4.5.6.    Sweden
4.5.7.    Russia
4.5.8.    Rest of Europe

5.    Europe Prefilled Syringes Market: Competitive Landscape
5.1.    STELLAR Competition Matrix
5.2.    Competitive Landscape
5.3.    Key Players Benchmarking
5.3.1.    Company Name
5.3.2.    Service Segment
5.3.3.    End-user Segment 
5.3.4.    Revenue (2023)
5.3.5.    Company Locations

5.4.    Leading Europe Prefilled Syringes Market Companies, by market capitalization
5.5.    Market Structure
5.5.1.    Market Leaders 
5.5.2.    Market Followers
5.5.3.    Emerging Players

5.6.    Mergers and Acquisitions Details
6.    Company Profile: Key Players
6.1.    Delta Med SpA 
6.1.1.    Company Overview
6.1.2.    Business Portfolio
6.1.3.    Financial Overview
6.1.4.    SWOT Analysis
6.1.5.    Strategic Analysis
6.1.6.    Scale of Operation (small, medium, and large)
6.1.7.    Details on Partnership
6.1.8.    Regulatory Accreditations and Certifications Received by Them
6.1.9.    Awards Received by the Firm
6.1.10.     Recent Developments

6.2.    Onko Kocsel
6.3.    Italfarmaco
6.4.    Polpharma
6.5.    ROVI
6.6.    Becton, Dickinson and Company (BD) 
6.7.    Gerresheimer AG 
6.8.    Schott AG 
6.9.    Stevanato Group 
6.10.    Fresenius Kabi AG
6.11.    Vetter Pharma International GmbH 
7.    Key Findings
8.    Industry Recommendations

Enquiry Before Buy

Request Sample PDF